High-Dose CRT Plus Watchful Waiting May Be Safe Alternative for Distal Rectal Cancer

Share this content:
High-dose chemoradiotherapy and watchful waiting might be safe alternative to abdominoperineal resection for treatment of rectal cancer.
High-dose chemoradiotherapy and watchful waiting might be safe alternative to abdominoperineal resection for treatment of rectal cancer.

High-dose chemoradiotherapy and watchful waiting might be a safe alternative to abdominoperineal resection for the treatment of patients with distal rectal cancer, a new study published online ahead of print in the journal The Lancet Oncology has shown.

The standard approach for the treatment of patients with distal T2 or T3 rectal cancers is abdominoperineal resection, but that procedure has various drawbacks.

Therefore, researchers sought to investigate whether high-dose radiotherapy plus concomitant chemotherapy followed by watchful waiting was a successful alternative strategy.

Researchers enrolled 55 patients with primary, resectable, T2 or T3, N0-N1 adenocarcinoma in the lower 6 cm of the rectum.

All patients received chemoradiotherapy every weekday for 6 weeks. If patients then achieved a clinical complete response, they were allocated to watchful waiting and those who did not received standard surgery.

RELATED: mFOLFOX6 Plus Radiotherapy Results in Higher pCR in Rectal Cancer

Results showed that of the 51 evaluable patients, 40 achieved a clinical complete response and went on to be observed. Researchers found that the 1-year local tumor recurrence rate in the watchful waiting group was 15.5% (95% CI: 3.3, 26.3).

In regard to safety, the most common acute grade 3 adverse event was diarrhea and the most common late toxicity was bleeding from the rectal mucosa. The study demonstrated excellent sphincter function among patients in the observation group.

Reference

  1. Appelt AL, Ploen J, Harling H, et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. The Lancet Oncol. 2015. [epub ahead of print]. doi: 10.1016/S1470-2045(15)00120-5.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters